Press release
In-Depth Examination of Segments, Industry Developments, and Key Players in the Pharma Grade Cellulose Powder Market
The pharma grade cellulose powder market is positioned for notable expansion over the coming years, driven by evolving demands across multiple sectors. As pharmaceutical and nutraceutical industries adapt to changing consumer preferences and regulatory landscapes, this market is expected to experience steady growth fueled by innovation and sustainability efforts. Let's explore the market size projections, key players, influential trends, and the segmentation that define this sector's trajectory.Pharma Grade Cellulose Powder Market Size and Growth Projections
Forecasts indicate that the pharma grade cellulose powder market will reach a value of $2.09 billion by 2030, expanding at a compound annual growth rate (CAGR) of 6.1%. This upward trend is largely supported by increasing applications in nutraceuticals, heightened demand for clean-label excipients, the broadening pipeline of generic drugs, advancements in excipient engineering, and a stronger focus on sustainability throughout the supply chain. Key trends shaping the market include a surge in plant-based pharmaceutical excipients, wider utilization in solid oral dosage forms, growing preference for microcrystalline cellulose, development of multifunctional cellulose excipients, and an emphasis on sourcing that prioritizes environmental responsibility.
Download a free sample of the pharma grade cellulose powder market sample:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24373&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Companies Driving the Pharma Grade Cellulose Powder Market
The market is dominated by several prominent companies, including Roquette Frères, Ashland Global, JRS Pharma, DFE Pharma, Sigachi Industries Ltd., Accent Microcell Ltd., FMC Corporation, Dow Chemical Company, Shin-Etsu Chemical Co. Ltd., Colorcon, Nippon Paper Industries Co. Ltd., Rayonier Advanced Materials, Lotte Fine Chemical, Mingtai Chemical Co. Ltd., Weifang Lude Chemical Co. Ltd., Shandong Head Co. Ltd., Zhejiang Kehong Chemical Co. Ltd., Anhui Sunhere Pharmaceutical Excipients Co. Ltd., Maple Biotech Pvt. Ltd., and Ankit Pulps & Boards Pvt. Ltd. These companies play a crucial role in pushing technological advances and expanding production capacities internationally.
Sustainability Efforts Highlighted in Recent Industry Collaborations
In December 2024, Nordic Bioproducts Group, based in Finland and a manufacturer of microcrystalline cellulose (MCC), formed a partnership with Spain's C.Q. Massó to boost the supply of sustainable MCC specifically for beauty and personal care products. This collaboration supports compliance with evolving EU regulations concerning harmful ingredients and product traceability. MCC, derived from renewable wood sources, offers an eco-friendly alternative to materials like talc and titanium dioxide. By providing a traceable and greener supply chain, this partnership reinforces the industry's move toward safer and more sustainable formulations across Europe.
View the full pharma grade cellulose powder market report:
https://www.thebusinessresearchcompany.com/report/pharma-grade-cellulose-powder-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Expansion of Production Facilities to Meet Growing Demand
To strengthen supply chains and increase production, major players are investing in new microcrystalline cellulose manufacturing plants. Such facilities use specialized chemical and mechanical processes to create uniform, fine-grade cellulose particles for pharmaceutical use. For example, in September 2023, India-based Nitika Pharmaceuticals Specialties launched Tabcell, the country's largest MCC plant located in Nagpur. Featuring advanced technology and an installed capacity of 1200 metric tons, this plant was inaugurated by Union Minister Nitin Gadkari. It represents a significant achievement under India's Production Linked Incentive (PLI) scheme for excipients, enhancing the company's global presence by serving domestic needs and exporting to over 92 countries. This development also supports the "Make in India" initiative and generates substantial employment locally.
Breakdown of Pharma Grade Cellulose Powder Market Segments
The pharma grade cellulose powder market is segmented into the following categories for deeper insight:
1) Product Types: Microcrystalline Cellulose (MCC), Carboxymethyl Cellulose (CMC), Hydroxypropyl Methylcellulose (HPMC), and Hydroxypropyl Cellulose (HPC)
2) Functionalities: Binding Agent, Thickening Agent, Stabilizer, Disintegrant, and Coating Agent
3) Applications: Pharmaceuticals, Nutraceuticals, Cosmetics, and Other Uses
4) End-Users: Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, dietary supplement* Manufacturers, and Food & Beverage Industries
Further detailed subsegments include:
- For MCC: Powder and Granules
- For CMC: Sodium CMC, Calcium CMC, and other CMC variants
- For HPMC: Low, Medium, and High Viscosity Grades
- For HPC: Low Substitution and High Substitution Grades
This detailed segmentation helps identify specific areas of growth and innovation within the pharma grade cellulose powder landscape, supporting targeted strategies and market development.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release In-Depth Examination of Segments, Industry Developments, and Key Players in the Pharma Grade Cellulose Powder Market here
News-ID: 4500266 • Views: …
More Releases from The Business Research Company
Percutaneous Puncture Surgery Robot Market Analysis Highlights Growth To $3.54 B …
The market for percutaneous puncture surgery robots is on the verge of significant expansion, driven by rapid technological advances and increasing adoption in healthcare settings. As robotic systems become more sophisticated and integrated with cutting-edge technologies, this sector is set to transform minimally invasive surgical procedures. Below is a detailed exploration of the market's size, key players, trends, and segmentation that shape its future trajectory.
Projected Growth and Market Size of…
Pedicle Screw Systems Market Study Highlights How Industry Demand Is Evolving
The pedicle screw systems market is set to experience significant expansion in the coming years, driven by advancements in spinal surgery techniques and increasing patient demand. This market's evolution reflects growing medical needs and ongoing innovation, positioning it for substantial growth by 2030.
Forecasted Market Size and Growth Trajectory for Pedicle Screw Systems
The value of the pedicle screw systems market is projected to reach $7.65 billion by 2030, growing…
Pediatric Orthopedic Implants Market Research Reveals Strong 10.8% CAGR Outlook …
The pediatric orthopedic implants market is on track for significant expansion as advancements in technology and growing healthcare needs drive demand. Innovations in implant design and personalized treatment options are setting the stage for transformative growth in this specialized segment of medical devices. Below is a detailed overview of the current market size, key industry players, emerging trends, and segmentation that define this market's future.
Pediatric Orthopedic Implants Market Size and…
Pediatric Interventional Cardiology Market Intelligence Report Covers Trends, Se …
The pediatric interventional cardiology field is on track for significant expansion, driven by advances in medical technology and growing demand for specialized cardiac care for children. This sector is expected to see dynamic growth as innovative devices and techniques become more widely adopted to improve patient outcomes.
Projected Market Size and Growth Trajectory of the Pediatric Interventional Cardiology Market
The market for pediatric interventional cardiology is forecasted to grow steadily,…
More Releases for Pharma
Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten …
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed…
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
